Financhill
Sell
7

EWTX Quote, Financials, Valuation and Earnings

Last price:
$21.80
Seasonality move :
-3.3%
Day range:
$21.52 - $23.12
52-week range:
$14.90 - $38.12
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
4.56x
Volume:
1.5M
Avg. volume:
1.4M
1-year change:
20.61%
Market cap:
$2.1B
Revenue:
--
EPS (TTM):
-$1.45
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $15M $32.2M $54M $90.9M $127M
Selling, General & Admin $2.2M $11M $17.6M $23.5M $31.9M
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $17.2M $43.2M $71.7M $114.4M $158.8M
Operating Income -$17.2M -$43.2M -$71.7M -$114.4M -$158.8M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$17.1M -$42.8M -$67.6M -$100.2M -$133.8M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -$17.1M -$42.8M -$67.6M -$100.2M -$133.8M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$17.1M -$42.8M -$67.6M -$100.2M -$133.8M
 
Basic EPS (Cont. Ops) -$0.37 -$1.14 -$1.26 -$1.57 -$1.45
Diluted EPS (Cont. Ops) -$0.37 -$1.14 -$1.26 -$1.57 -$1.45
Weighted Average Basic Share $46.6M $37.5M $53.6M $63.7M $92.4M
Weighted Average Diluted Share $46.6M $37.5M $53.6M $63.7M $92.4M
 
EBITDA -$17M -$42.9M -$71.1M -$112.6M -$156.5M
EBIT -$17.2M -$43.2M -$71.7M -$114.4M -$158.8M
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -$17.2M -$43.2M -$71.7M -$114.4M -$158.8M
Operating Income (Adjusted) -$17.2M -$43.2M -$71.7M -$114.4M -$158.8M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $5.1M $9.1M $16.6M $27.7M $36.4M
Selling, General & Admin $1.2M $3.7M $5.5M $6.2M $9.2M
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $6.3M $12.8M $22.1M $33.9M $45.5M
Operating Income -$6.3M -$12.8M -$22.1M -$33.9M -$45.5M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$6.3M -$12.7M -$19.4M -$30.1M -$39.7M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -$6.3M -$12.7M -$19.4M -$30.1M -$39.7M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$6.3M -$12.7M -$19.4M -$30.1M -$39.7M
 
Basic EPS (Cont. Ops) -$0.14 -$0.24 -$0.30 -$0.47 -$0.42
Diluted EPS (Cont. Ops) -$0.14 -$0.24 -$0.30 -$0.47 -$0.42
Weighted Average Basic Share $46.6M $49.5M $63.3M $64.8M $94.7M
Weighted Average Diluted Share $46.6M $49.5M $63.3M $64.8M $94.7M
 
EBITDA -$6.3M -$12.7M -$22M -$33.3M -$44.9M
EBIT -$6.3M -$12.8M -$22.1M -$33.9M -$45.5M
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -$6.3M -$12.8M -$22.1M -$33.9M -$45.5M
Operating Income (Adjusted) -$6.3M -$12.8M -$22.1M -$33.9M -$45.5M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $15M $32.2M $54M $90.9M $127M
Selling, General & Admin $2.2M $11M $17.6M $23.5M $31.9M
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $17.2M $43.2M $71.7M $114.4M $158.8M
Operating Income -$17.2M -$43.2M -$71.7M -$114.4M -$158.8M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$17.1M -$42.8M -$67.6M -$100.2M -$133.8M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -$17.1M -$42.8M -$67.6M -$100.2M -$133.8M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$17.1M -$42.8M -$67.6M -$100.2M -$133.8M
 
Basic EPS (Cont. Ops) -$0.67 -$5.08 -$1.26 -$1.58 -$1.45
Diluted EPS (Cont. Ops) -$0.67 -$5.08 -$1.26 -$1.58 -$1.45
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA -$17M -$42.9M -$71.1M -$112.6M -$156.5M
EBIT -$17.2M -$43.2M -$71.7M -$114.4M -$158.8M
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -$17.2M -$43.2M -$71.7M -$114.4M -$158.8M
Operating Income (Adjusted) -$17.2M -$43.2M -$71.7M -$114.4M -$158.8M
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $32.2M $54M $90.9M $127M --
Selling, General & Admin $11M $17.6M $23.5M $31.9M --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $43.2M $71.7M $114.4M $158.8M --
Operating Income -$43.2M -$71.7M -$114.4M -$158.8M --
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$42.8M -$67.6M -$100.2M -$133.8M --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -$42.8M -$67.6M -$100.2M -$133.8M --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$42.8M -$67.6M -$100.2M -$133.8M --
 
Basic EPS (Cont. Ops) -$5.08 -$1.26 -$1.58 -$1.45 --
Diluted EPS (Cont. Ops) -$5.08 -$1.26 -$1.58 -$1.45 --
Weighted Average Basic Share $149.6M $214.3M $254.9M $369.6M --
Weighted Average Diluted Share $149.6M $214.3M $254.9M $369.6M --
 
EBITDA -$42.9M -$71.1M -$112.6M -$156.5M --
EBIT -$43.2M -$71.7M -$114.4M -$158.8M --
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -$43.2M -$71.7M -$114.4M -$158.8M --
Operating Income (Adjusted) -$43.2M -$71.7M -$114.4M -$158.8M --
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $104.9M $15.6M $22M $86.1M $41.7M
Short Term Investments $24.2M $265.2M $330M $232.3M $428.5M
Accounts Receivable, Net -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- --
Other Current Assets $551K $3M $5.1M $8.6M $5.3M
Total Current Assets $129.6M $283.8M $357M $327M $475.5M
 
Property Plant And Equipment $516K $912K $9.9M $12.7M $11.1M
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $975K $548K $251K $348K $262K
Total Assets $131.1M $285.2M $367.1M $340M $486.8M
 
Accounts Payable $1.6M $3.8M $6.1M $4M $5.6M
Accrued Expenses $1.6M $3.9M $5.8M $6.1M $7.2M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- $608K $980K $996K
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $4.3M $10.5M $16.6M $16.8M $23.9M
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $164.6M $10.9M $20.4M $21.2M $27.6M
 
Common Stock -- $5K $6K $7K $9K
Other Common Equity Adj -- -$514K -$1.4M $99K $420K
Common Equity -$33.4M $274.4M $346.7M $318.8M $459.2M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -$33.4M $274.4M $346.7M $318.8M $459.2M
 
Total Liabilities and Equity $131.1M $285.2M $367.1M $340M $486.8M
Cash and Short Terms $129.1M $280.8M $351.9M $318.4M $470.2M
Total Debt -- -- -- -- --
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $104.9M $15.6M $22M $86.1M $41.7M
Short Term Investments $24.2M $265.2M $330M $232.3M $428.5M
Accounts Receivable, Net -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- --
Other Current Assets $551K $3M $5.1M $8.6M $5.3M
Total Current Assets $129.6M $283.8M $357M $327M $475.5M
 
Property Plant And Equipment $516K $912K $9.9M $12.7M $11.1M
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $975K $548K $251K $348K $262K
Total Assets $131.1M $285.2M $367.1M $340M $486.8M
 
Accounts Payable $1.6M $3.8M $6.1M $4M $5.6M
Accrued Expenses $1.6M $3.9M $5.8M $6.1M $7.2M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- $608K $980K $996K
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $4.3M $10.5M $16.6M $16.8M $23.9M
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $164.6M $10.9M $20.4M $21.2M $27.6M
 
Common Stock -- $5K $6K $7K $9K
Other Common Equity Adj -- -$514K -$1.4M $99K $420K
Common Equity -- -- -- -- --
Total Preferred Equity $95M -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -$33.4M $274.4M $346.7M $318.8M $459.2M
 
Total Liabilities and Equity $131.1M $285.2M $367.1M $340M $486.8M
Cash and Short Terms $129.1M $280.8M $351.9M $318.4M $470.2M
Total Debt -- -- -- -- --
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders -$17.1M -$42.8M -$67.6M -$100.2M -$133.8M
Depreciation & Amoritzation $185K $272K $538K $1.7M $2.3M
Stock-Based Compensation $354K $4.4M $10.9M $17.6M $24.7M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -$14.6M -$33.5M -$52.6M -$91.9M -$109M
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -$24.4M -$242.2M -$70.6M $102.9M -$184.7M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -$124K -$251K -$165K -$262K
Cash From Financing $120.3M $186.4M $129.6M $53.2M $249.3M
 
Beginning Cash (CF) $23.7M $104.9M $15.6M $22M $86.1M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $81.3M -$89.4M $6.4M $64.1M -$44.4M
Ending Cash (CF) $104.9M $15.6M $22M $86.1M $41.7M
 
Levered Free Cash Flow -$14.8M -$34.2M -$58.2M -$97.7M -$110.3M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders -$6.3M -$12.7M -$19.4M -$30.1M -$39.7M
Depreciation & Amoritzation $50K $78K $92K $533K $629K
Stock-Based Compensation $190K $1.9M $3.7M $5.2M $7.7M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -$4.6M -$9.4M -$11.9M -$26.8M -$27M
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -$24.2M $14.1M -$75.6M $27M $20.9M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- $85K $49K --
Cash From Financing $95M $293K -$303K $53M $2.9M
 
Beginning Cash (CF) $38.7M $10.6M $109.7M $33M $44.8M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $66.2M $5M -$87.8M $53.1M -$3.1M
Ending Cash (CF) $104.9M $15.6M $22M $86.1M $41.7M
 
Levered Free Cash Flow -$4.6M -$9.5M -$15.1M -$27M -$27.2M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders -$17.1M -$42.8M -$67.6M -$100.2M -$133.8M
Depreciation & Amoritzation $185K $272K $538K $1.7M $2.3M
Stock-Based Compensation $354K $4.4M $10.9M $17.6M $24.7M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -$14.6M -$33.5M -$52.6M -$91.9M -$109M
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -$24.4M -$242.2M -$70.6M $102.9M -$184.7M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -$124K -- -- --
Cash From Financing $120.3M $186.4M $129.6M $53.2M $249.3M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $81.3M -$89.4M $6.4M $64.1M -$44.4M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -$14.8M -$34.2M -$58.2M -$97.7M -$110.3M
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Net Income to Stockholders -$42.8M -$67.6M -$100.2M -$133.8M --
Depreciation & Amoritzation $272K $538K $1.7M $2.3M --
Stock-Based Compensation $4.4M $10.9M $17.6M $24.7M --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -$33.5M -$52.6M -$91.9M -$109M --
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -$242.2M -$70.6M $102.9M -$184.7M --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$124K -$251K -$165K -$262K --
Cash From Financing $186.4M $129.6M $53.2M $249.3M --
 
Beginning Cash (CF) $386.9M $178.1M $135M $204.7M --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$89.4M $6.4M $64.1M -$44.4M --
Ending Cash (CF) $297.6M $184.5M $199.1M $160.2M --
 
Levered Free Cash Flow -$34.2M -$58.2M -$97.7M -$110.3M --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

3 Smartest Dividend Stocks to Buy Now
3 Smartest Dividend Stocks to Buy Now

When the market entered a correction in February and March,…

How High Could IBIT Go?
How High Could IBIT Go?

Recently, a surprising number of billionaire hedge fund managers have…

Is Raymond James Stock a Buy, Sell or Hold?
Is Raymond James Stock a Buy, Sell or Hold?

Raymond James Financial (NYSE:RJF) is one of America’s large financial…

Stock Ideas

Buy
56
Is AAPL Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Sell
46
Is MSFT Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 32x

Sell
41
Is NVDA Stock a Buy?

Market Cap: $2.6T
P/E Ratio: 37x

Alerts

Buy
80
CORT alert for Apr 1

Corcept Therapeutics [CORT] is down 15.17% over the past day.

Sell
16
PCVX alert for Apr 1

Vaxcyte [PCVX] is down 3.39% over the past day.

Sell
47
RGC alert for Apr 1

Regencell Bioscience Holdings [RGC] is down 4.55% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock